Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 3/20 | 0.69 |
| ▸ | CYP1A1 | P04798 | 3/20 | 0.69 |
| ▸ | CYP1B1 | Q16678 | 3/20 | 0.69 |
| ▸ | CYP3A4 | P08684 | 5/20 | 0.62 |
| ▸ | CYP2C19 | P33261 | 4/20 | 0.62 |
| ▸ | HPGD | P15428 | 4/20 | 0.62 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.62 |
| ▸ | MAPT | P10636 | 3/20 | 0.62 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.62 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.62 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.62 |
| ▸ | MEN1 | O00255 | 2/20 | 0.62 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.62 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.62 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.62 |
| ▸ | RECQL | P46063 | 1/20 | 0.62 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.62 |
| ▸ | TSHR | P16473 | 1/20 | 0.60 |
| ▸ | NCOA1 | Q15788 | 1/20 | 0.59 |
| ▸ | NCOA3 | Q9Y6Q9 | 1/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6616218 | 0.88 | CYP3A4 (0.73) | CYP1A2CYP1A1CYP1B1CYP3A4CYP2C19 | |
| SCHEMBL6616325 | 0.86 | ALDH1A1 (0.60) | CYP1A2CYP1A1CYP1B1CYP3A4CYP2C19 | |
| SCHEMBL6801603 | 0.86 | CYP3A4 (0.65) | CYP1A2CYP1A1CYP1B1CYP3A4CYP2C19 | |
| SCHEMBL29411332 | 0.82 | ACHE (0.76) | CYP1A2CYP1A1CYP1B1CYP3A4CYP2C19 | |
| SCHEMBL16894649 | 0.82 | CYP1A1 (0.65) | CYP1A2CYP1A1CYP1B1CYP3A4ALDH1A1 | |
| SCHEMBL6069761 | 0.82 | ACHE (0.76) | CYP1A2CYP1A1CYP1B1CYP3A4CYP2C19 | |
| SCHEMBL28442531 | 0.82 | CYP3A4 (0.56) | CYP1A2CYP1A1CYP1B1CYP3A4CYP2C19 | |
| SCHEMBL4649487 | 0.82 | CYP3A4 (0.76) | CYP1A2CYP1A1CYP1B1CYP3A4CYP2C19 | |
| SCHEMBL28440242 | 0.82 | CYP3A4 (0.55) | CYP1A2CYP1A1CYP1B1CYP3A4CYP2C19 | |
| SCHEMBL6613755 | 0.81 | TERT (0.77) | CYP1A2CYP1A1CYP1B1CYP3A4CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040063665-A1 | Substituted benzopyranones as telomerase inhibitors | PHARMACIA ITALIA S.P.A. (IT) | 2004-04-01 | — | — | US | disclosed |
| EP-1373244-A2 | SUBSTITUTED BENZOPYRANONES AS TELOMERASE INHIBITORS | Pharmacia Italia S.p.A. (IT) | 2004-01-02 | — | — | EP | disclosed |
| US-20020160983-A1 | Substituted benzopyranones as telomerase inhibitors | PHARMACIA ITALIA S.P.A. (IT) | 2002-10-31 | — | — | US | disclosed |
| WO-2002074036-A2 | SUBSTITUTED BENZOPYRANONES AS TELOMERASE INHIBITORS | PHARMACIA ITALIA SPA (IT) | 2002-09-26 | — | — | WO | disclosed |
| EP-0332478-A1 | Liposomes containing Scutellaria extracts | LVMH RECHERCHE (FR) | 1989-09-13 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020160983-A1 | Substituted benzopyranones as telomerase inhibitors | TERT, TERF2, TERF2IP | CYP1A2 3159/4885CYP1A1 2499/4885CYP1B1 2221/4885 |
| US-20040063665-A1 | Substituted benzopyranones as telomerase inhibitors | TERT, TERF2, TERF2IP | CYP1A2 3209/4885CYP1A1 2558/4885CYP1B1 2288/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.